CBD

Can you take CBD during pregnancy?

Updated:

Key facts

  • •Professional bodies: advise against
  • •FDA warning since 2019
  • •Passage into breast milk documented
  • •Discuss safer alternatives with doctor

Detailed explanation

The FDA has warned since 2019 against CBD in pregnancy and breastfeeding. Reason: animal studies suggest reproductive toxicity and fetal development disruption; CBD passage into breast milk is documented. Controlled human studies are lacking. "Plant-based" does not mean "safe". For symptoms like insomnia or anxiety, safer alternatives (therapy, approved medications) should be discussed with a gynaecologist.

Background and legal framework

In Switzerland, the Federal Office of Public Health (FOPH) and Swissmedic regulate CBD products. While CBD containing less than 1% THC is legally sold under the Narcotics Act (BetmG), its safety during pregnancy remains a major public health concern. The ongoing Swiss cannabis pilot projects in cities like Zurich, Basel, Bern, Lausanne, and Geneva strictly exclude pregnant and breastfeeding individuals from participation for safety reasons. Swissmedic classifies CBD products according to their intended use, but no over-the-counter CBD is approved as a safe prenatal supplement. This strict regulatory caution reflects the precautionary principle applied by Swiss health authorities to protect fetal development.

Common misconceptions

A common misconception in Switzerland is that commercial CBD is completely THC-free. Under Swiss law, CBD products can legally contain up to 1% THC. This means consuming CBD could expose the fetus to trace amounts of THC, which easily crosses the placenta. Another false assumption is that topical CBD cosmetics are entirely safe during pregnancy. While skin absorption is lower than ingestion, some cannabinoids can still enter the bloodstream. Finally, many believe that because CBD is sold in Swiss pharmacies and health shops, it has been tested for prenatal safety. In reality, these lifestyle products bypass the rigorous clinical trials required for pharmaceutical pregnancy clearance.

What this means in practice

For an adult in Switzerland, this means adopting a strict precautionary approach. If you are pregnant or planning to conceive, you should completely avoid purchasing or consuming any CBD products. Under BetmG Art. 19a/28b, public consumption of THC cannabis is illegal, and carrying over 10 grams of illegal cannabis can result in a CHF 100 fixed penalty, but during pregnancy, even legal CBD should be entirely avoided. Additionally, if you drive, remember Switzerland enforces a strict limit of 1.5 micrograms of THC per litre of blood. To manage prenatal symptoms, discuss Swissmedic-approved, non-cannabinoid therapies with your gynaecologist.

Follow-up questions

What about using CBD skincare products during pregnancy?

While topical absorption is generally lower than oral ingestion, some CBD and trace THC from cosmetics can still enter your bloodstream. Because Swiss cosmetic regulations do not require safety testing specifically for pregnant women, gynaecologists advise avoiding CBD-infused skincare, oils, and balms during pregnancy to eliminate any unnecessary risk to the developing fetus.

Are pregnant women allowed to participate in Swiss cannabis pilot trials?

No, pregnant and breastfeeding women are strictly excluded from all Swiss cannabis pilot projects, such as those in Zurich, Basel, Bern, Lausanne, and Geneva. These state-supervised studies follow rigorous public health protocols under the Federal Office of Public Health. To protect maternal and fetal health, participants must immediately withdraw if they become pregnant during the trial.

— Stronger together

Rethinking CBD together

Our goal is attractive CBD offers through collective demand. Each drop will state its availability and terms.

members • the movement grows
Become a member — free

Related questions

How do I become a member of CannabisClub.ch?+

Register for free to create your member account. Invite friends with your personal referral link: you receive a 10% revenue share on their orders. Information about upcoming drops and their terms will be published in the member area; an account does not guarantee available stock.

No invite code needed — open to all adults in Switzerland.

Sources

  1. WHO – Cannabidiol (CBD) Critical Review — World Health Organization
  2. Swissmedic – Cannabisarzneimittel — Swissmedic
— SEMANTIC GRAPH

Related in the knowledge graph

Continue learning